Oryzon to present at upcoming international conferences

MADRID, SPAIN and CAMBRIDGE MA.

• European Biotech Investor Day in NYC, New York, USA

• The Alzheimer's Association International Conference AAIC- 2018 – Chicago, USA

Oryzon Genomics (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, has announced today that Executive Directors of the company will present at several international reputed conferences in July.

Click here to see the full Press Release